Every claim we hold, and how far we can stand behind it.
142 claims across 39 products. 28% are confirmed against the source text by the evidence gate; 39% come from a class with no vendor interest. Everything below is browsable, filterable, and available as JSON.
| Evidence class | Claims | Confirmed | What it can support |
|---|---|---|---|
| Peer-reviewed study | 19 | 5 | Reviewed before publication; assess study quality, funding, conflicts, and relevance to your setting. |
| Regulatory filing | 4 | 0 | A statement made to a regulator, where being wrong has consequences. |
| Independent report | 32 | 9 | Reporting outside a vendor publication; assess underlying data, sponsorship, and conflicts separately. |
| Customer case | 4 | 3 | A real deployment, but selected and framed by someone with an interest. |
| Press release | 63 | 22 | The vendor's own announcement. Useful for dates and facts, not for outcomes. |
| Vendor page | 20 | 1 | Marketing copy. Establishes what is claimed, never that it is true. |
Showing 3 of 3 matching claims (142 in the full corpus) · 0% of this selection is confirmed · clear filters
OpenEvidence, a tool that doctors and nurses have likened to ChatGPT for medicine, planned to announce a $200 million raise at a $6 billion valuation; the round was led by Google Ventures, with participation from Sequoia Capital, Kleiner Perkins, Blackstone, Thrive Capital, Coatue Management, Bond, and Craft, and its number of clinical consultations per month has nearly doubled to 15 million since July.
Provenance
- Claim ID
- clm_13448bdf904435ba7eda
- Version
- 1
- Workflow
- Clinical Evidence & Decision Support
- Dimension
- economic value
- Retrieved
- 2026-08-27
- Reviewer
- healthit-gate-v1
- Source URL
- https://techcrunch.com/2025/10/20/openevidence-the-chatgpt-for-doctors-raises-200m-at-6b-valuation/
Glass Health (YC W23) launched an LLM-powered tool that generates differential diagnoses and evidence-based treatment options from clinician-entered patient summaries, with roughly $6.5M in total funding including a $5M seed led by Initialized Capital
Provenance
- Claim ID
- clm_b2412c30d73fb2826021
- Version
- 1
- Workflow
- Clinical Evidence & Decision Support
- Dimension
- general
- Retrieved
- 2026-08-27
- Reviewer
- healthit-gate-v1
- Source URL
- https://techcrunch.com/2023/09/08/glass-health-is-building-an-ai-for-suggesting-medical-diagnoses/
Infermedica raised a $30M Series B led by One Peak (January 2022), bringing total funding to roughly $44M, to expand its AI-based medical guidance platform
Provenance
- Claim ID
- clm_aadc47ac08fc4c144849
- Version
- 1
- Workflow
- Clinical Evidence & Decision Support
- Dimension
- market durability
- Retrieved
- 2026-08-27
- Reviewer
- healthit-gate-v1
- Source URL
- https://techcrunch.com/2022/01/25/infermedica-raises-30m-to-expand-its-ai-based-medical-guidance-platform/